Chromocell Therapeutics Corporation (CHRO)

NYSEAMERICAN: CHRO · Real-Time Price · USD

0.660

+0.029 (4.60%)

At close: Nov 22, 2024, 4:00 PM

0.625

-0.035 (-5.29%)

After-hours: Nov 22, 2024, 5:54 PM EST

Chromocell Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '24 Nov 22, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	4	-	-	-	-
Enterprise Value	5	-	-	-	-
Debt / Equity Ratio	-1.60	-0.20	-0.15	-0.30	-0.07
Quick Ratio	0.35	0.01	0.01	-	-
Current Ratio	0.60	0.01	0.01	-	0.02
Return on Assets (ROA)	-556.33%	-5663.30%	-	-	-
Buyback Yield / Dilution	-333.40%	-193.25%	-	-	-
Total Shareholder Return	-333.40%	-193.25%	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.